Zhimin Zeng
9PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 27, 2026
The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial.Zhimin Zeng, Wenqian Huang, Fujuan Zeng
|Jan 12, 2024
Association between serum C-reactive protein (CRP) and Omicron variant COVID-19 pneumonia in cancer patients: A multicenter cross-sectional study at the end of 2022 in China.Kaijun Che, Zhimin Zeng, Chen Hong
|Nov 06, 2023
Association of immune-related adverse events with COVID-19 pneumonia in lung cancer patients receiving immune checkpoint inhibitors: a cross-sectional study in China.Kaijun Che, Chen Hong, Yanqing He
|Dec 17, 2022
Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non-small-cell lung cancer patients: a prospective observational study.Duanyang Peng, Pingan Liang, Congying Zhong
|Nov 25, 2022
Arrhythmic events associated with immune checkpoint inhibitors therapy: A real-world study based on the Food and Drug Administration Adverse Event Reporting System database.Yunwei Liu, Yanxin Chen, Zhimin Zeng
|Oct 30, 2022
Immune Checkpoint Inhibitors and Tuberculosis Infection in Lung Cancer: A Case Series and Systematic Review With Pooled Analysis.Yanqing He, Duanyang Peng, Pingan Liang
Pageof 2
